SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+1.06%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$1.2B
AUM Growth
+$1.2B
(-2.7%)
Cap. Flow
+$10.6M
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
22.6%
Holding
147
New
20
Increased
35
Reduced
44
Closed
20
Top Buys
| 1 |
EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
|
$40.5M |
| 2 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$23.5M |
| 3 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$23.4M |
| 4 |
Health Catalyst
HCAT
|
$22.1M |
| 5 |
Rapid Micro Biosystems
RPID
|
$9.44M |
Top Sells
| 1 |
Repligen
RGEN
|
$22.5M |
| 2 |
Teleflex
TFX
|
$21.1M |
| 3 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$20.4M |
| 4 |
OSH
Oak Street Health, Inc.
OSH
|
$18.8M |
| 5 |
NeueHealth
NEUE
|
$15.7M |
Sector Composition
| 1 | Healthcare | 94.67% |
| 2 | Industrials | 4.36% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Exact Sciences
EXAS
$9.33B
| $6.46M | 0.54% |
67,700
+9,200
| +16% | +$878K |
|
77
Denali Therapeutics
DNLI
$2.24B
| $6.43M | 0.53% |
127,500
+62,500
| +96% | +$3.15M |
|
78
Alignment Healthcare
ALHC
$3.23B
| $6.41M | 0.53% |
401,145
-444,842
| -53% | -$7.11M |
|
79
Moderna
MRNA
$9.36B
| $6.39M | 0.53% |
16,605
+3,955
| +31% | +$1.52M |
|
80
Ascendis Pharma
ASND
$12.1B
| $6.16M | 0.51% |
38,650
+35,100
| +989% | +$5.59M |
|
81
STAAR Surgical
STAA
$1.35B
| $6.08M | 0.51% |
47,300
+4,300
| +10% | +$553K |
|
82
Tenet Healthcare
THC
$16.5B
| $5.91M | 0.49% |
89,000
+4,000
| +5% | +$266K |
|
83
Quanterix
QTRX
$202M
| $5.79M | 0.48% |
116,186
-18,000
| -13% | -$896K |
|
|
SWAV
84
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $5.77M | 0.48% |
28,000
| – | – |
|
85
Merck
MRK
$210B
| $5.65M | 0.47% |
75,250
| – | – |
|
86
Natera
NTRA
$23B
| $5.56M | 0.46% |
49,850
| – | – |
|
87
Biogen
BIIB
$20.8B
| $5.5M | 0.46% |
19,432
| – | – |
|
88
Boston Scientific
BSX
$159B
| $5.47M | 0.45% |
125,976
+10,000
| +9% | +$434K |
|
89
NeoGenomics
NEO
$1.06B
| $5.43M | 0.45% |
+112,500
| New | +$5.43M |
|
90
Stevanato
STVN
$6.36B
| $5.38M | 0.45% |
+212,713
| New | +$5.38M |
|
91
Pfizer
PFE
$141B
| $5.2M | 0.43% |
120,900
-72,500
| -37% | -$3.12M |
|
92
Danaher
DHR
$143B
| $5.11M | 0.42% |
16,775
| – | – |
|
93
Medtronic
MDT
$118B
| $5.04M | 0.42% |
40,201
-36,900
| -48% | -$4.63M |
|
|
DCPH
94
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $4.81M | 0.4% |
+141,500
| New | +$4.81M |
|
|
BTTX
95
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
| $4.65M | 0.39% |
+466,200
| New | +$4.65M |
|
96
Progyny
PGNY
$2.02B
| $4.49M | 0.37% |
+80,100
| New | +$4.49M |
|
97
Bristol-Myers Squibb
BMY
$96.7B
| $4.32M | 0.36% |
73,074
-52,500
| -42% | -$3.11M |
|
|
AXNX
98
DELISTED
Axonics, Inc. Common Stock
AXNX
| $3.58M | 0.3% |
55,000
-313,650
| -85% | -$20.4M |
|
99
BeyondSpring
BYSI
$73.4M
| $3.42M | 0.28% |
+217,250
| New | +$3.42M |
|
|
ONCR
100
DELISTED
Oncorus, Inc.
ONCR
| $3.38M | 0.28% |
361,821
+26,821
| +8% | +$250K |
|